Nephrogenic Systemic Fibrosis (NSF)/Nephrogenic Fibrosing Dermopathy (NFD)

Chairs/Moderators:  Walter Kucharczyk, Georg Bongartz

Tuesday, 22 May



This symposium will provide an opportunity for the MRI community to share the latest information on this emerging disease complex,
the relationship to the administration of contrast material, and implications for clinical and research policies.

13:30         Nephrogenic Systemic Fibrosis:  What is it, and where does it come from?

Shawn Cowper, Yale University, New Haven, CT, USA

13:50         Relation to GD Exposure and on Differences among GD Chelates
                  Henrik S. Thomsen, Copenhagen University, Copenhagen, Denmark

14:10         Consequences for the MR Community – Alternative Diagnostic Pathways
Peter Dawson, University College, London, England, UK 

14:30         Legal and Regulatory Issues/The View of the U.S. Food & Drug Administration
  Panos Tsintis/Doris Stenver, EMEA - sector of Pharmacovigilance, London, UK - via teleconference

14:50         Roundtable Panel Discussion
All Speakers and Harm Peters, Nephrologist - University Hospital Charité, Berlin, Germany


Please click here to view this Special Symposium online.